Tenofovir disoproxil fumarate and emtricitabine maintenance strategy in virologically controlled adults with low HIV-1 DNA: 48 week results from a randomized, open-label, non-inferiority trial.
暂无分享，去创建一个
B. Giraudeau | J. Parienti | G. Pialoux | R. Verdon | L. Hocqueloux | L. Bernard | T. Prazuck | J. Viard | J. Michon | F. Ajana | A. de la Blanchardière | M. Etienne | D. Ponscarme | G. Le Moal | T. Pasdeloup | Iuliana Darasteanu | S. Sunder | M. Roncato-Sabéran | S. Dargère | V. Avettand-Fenoël | N. Juteau | Adeline Fourmy | Elody Mureau | Aurélie Baldoli